Sunshine Biopharma Inc. Increase (Decrease) in Accounts Payable
Sunshine Biopharma Inc. (SBFM) reported Increase (Decrease) in Accounts Payable of -$35.01 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2021-03-30
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2019-12-31 was $33.80K, a 49.57% decline year-over-year.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2019-09-30 was -$21.04K, a 441.23% decline year-over-year.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2019-06-30 was $21.98K.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2019-03-31 was -$53.43K.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for fiscal 2020 was -$35.01K.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for fiscal 2019 was -$18.69K, a 130.33% decline from fiscal 2018.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for fiscal 2018 was $61.63K.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable for fiscal 2017 was -$8.81K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 19 month | Increase (Decrease) in Accounts Payable 22 month | Increase (Decrease) in Accounts Payable 25 month | Increase (Decrease) in Accounts Payable 28 month | Increase (Decrease) in Accounts Payable 31 month | Increase (Decrease) in Accounts Payable 34 month | Increase (Decrease) in Accounts Payable 37 month | Increase (Decrease) in Accounts Payable 40 month | Increase (Decrease) in Accounts Payable 43 month | Increase (Decrease) in Accounts Payable 46 month | Increase (Decrease) in Accounts Payable 49 month | Increase (Decrease) in Accounts Payable 55 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$35.01K 10-K · filed 2021-03-30 | ||||||||||||||||
| 2019-12-31 | $33.80K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $12.76K derived: sum of 2 quarters · filed 2021-03-30 | $34.73K derived: sum of 3 quarters · filed 2021-03-30 | -$18.69K 10-K · filed 2021-03-30 | |||||||||||||
| 2019-09-30 | -$21.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $937.00 derived: sum of 2 quarters · filed 2019-11-13 | -$52.49K 10-Q · filed 2019-11-13 | $14.53K derived: sum of 4 quarters · filed 2020-05-01 | |||||||||||||
| 2019-06-30 | $21.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | -$31.45K 10-Q · filed 2019-08-15 | $35.57K derived: sum of 3 quarters · filed 2020-05-01 | $41.74K derived: sum of 4 quarters · filed 2020-05-01 | |||||||||||||
| 2019-03-31 | -$53.43K 10-Q · filed 2019-05-20 | $13.59K derived: sum of 2 quarters · filed 2020-05-01 | $19.76K derived: sum of 3 quarters · filed 2020-05-01 | $19.64K derived: sum of 4 quarters · filed 2020-05-01 | |||||||||||||
| 2018-12-31 | $67.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | $73.19K derived: sum of 2 quarters · filed 2020-05-01 | $73.06K derived: sum of 3 quarters · filed 2020-05-01 | $61.63K 10-K · filed 2020-05-01 | |||||||||||||
| 2018-09-30 | $6.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $6.04K derived: sum of 2 quarters · filed 2019-11-13 | -$5.39K 10-Q · filed 2019-11-13 | $2.13K derived: sum of 4 quarters · filed 2019-11-13 | |||||||||||||
| 2018-06-30 | -$122.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | -$11.56K 10-Q · filed 2019-08-15 | $14.23K 10-Q · filed 2018-08-17 | -$4.04K derived: sum of 3 quarters · filed 2019-08-15 | -$363.14K derived: sum of 4 quarters · filed 2019-08-15 | ||||||||||||
| 2018-03-31 | -$11.44K 10-Q · filed 2019-05-20 | -$3.92K derived: sum of 2 quarters · filed 2019-05-20 | -$363.02K derived: sum of 3 quarters · filed 2019-05-20 | -$20.07K derived: sum of 4 quarters · filed 2019-05-20 | |||||||||||||
| 2017-12-31 | $7.52K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-12 | -$351.58K derived: sum of 2 quarters · filed 2019-04-12 | -$8.64K derived: sum of 3 quarters · filed 2019-04-12 | -$8.81K 10-K · filed 2019-04-12 | |||||||||||||
| 2017-09-30 | -$359.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | -$16.16K derived: sum of 2 quarters · filed 2018-11-16 | -$16.33K 10-Q · filed 2018-11-16 | $72.51K derived: sum of 4 quarters · filed 2018-11-16 | |||||||||||||
| 2017-06-30 | $342.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17 | $342.77K 10-Q · filed 2018-08-17 | $431.61K derived: sum of 3 quarters · filed 2018-08-17 | $413.13K derived: sum of 4 quarters · filed 2018-08-17 | |||||||||||||
| 2017-03-31 | -$171.00 10-Q · filed 2018-05-22 | $88.67K derived: sum of 2 quarters · filed 2018-05-22 | $70.19K derived: sum of 3 quarters · filed 2018-05-22 | $32.98K derived: sum of 4 quarters · filed 2018-05-22 | |||||||||||||
| 2016-12-31 | $88.84K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $70.36K derived: sum of 2 quarters · filed 2018-04-02 | $33.16K derived: sum of 3 quarters · filed 2018-04-02 | -$18.96K 10-K · filed 2018-04-02 | |||||||||||||
| 2016-09-30 | -$18.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-15 | -$55.68K derived: sum of 2 quarters · filed 2017-11-15 | -$107.80K 10-Q · filed 2017-11-15 | -$95.85K derived: sum of 4 quarters · filed 2017-11-15 | |||||||||||||
| 2016-06-30 | -$37.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$89.32K 10-Q · filed 2017-08-11 | -$77.36K derived: sum of 3 quarters · filed 2017-08-11 | -$78.39K derived: sum of 4 quarters · filed 2017-08-11 | |||||||||||||
| 2016-03-31 | -$52.12K 10-Q · filed 2017-05-12 | -$40.16K derived: sum of 2 quarters · filed 2017-05-12 | -$41.19K derived: sum of 3 quarters · filed 2017-05-12 | -$52.12K derived: sum of 4 quarters · filed 2017-05-12 | |||||||||||||
| 2015-12-31 | $11.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $10.92K derived: sum of 2 quarters · filed 2017-04-17 | -$6.00 derived: sum of 3 quarters · filed 2017-04-17 | $11.82K 10-K · filed 2017-04-17 | |||||||||||||
| 2015-09-30 | -$1.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$11.96K derived: sum of 2 quarters · filed 2016-11-14 | -$129.00 10-Q · filed 2016-11-14 | -$16.68K derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||
| 2015-06-30 | -$10.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | $901.00 10-Q · filed 2016-08-16 | -$15.65K derived: sum of 3 quarters · filed 2016-08-16 | -$58.21K derived: sum of 4 quarters · filed 2016-08-16 | |||||||||||||
| 2015-03-31 | $11.83K 10-Q · filed 2016-05-09 | -$4.72K derived: sum of 2 quarters · filed 2016-05-09 | -$47.28K derived: sum of 3 quarters · filed 2016-05-09 | -$2.92K derived: sum of 4 quarters · filed 2016-05-09 | |||||||||||||
| 2014-12-31 | -$16.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$59.11K derived: sum of 2 quarters · filed 2016-03-25 | -$14.75K derived: sum of 3 quarters · filed 2016-03-25 | $10.96K 10-K · filed 2016-03-25 | |||||||||||||
| 2014-09-30 | -$42.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.81K derived: sum of 2 quarters · filed 2015-11-04 | $27.51K 10-Q · filed 2015-11-04 | $42.56K derived: sum of 4 quarters · filed 2015-11-04 | |||||||||||||
| 2014-06-30 | $44.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $70.06K 10-Q · filed 2015-08-06 | $85.11K derived: sum of 3 quarters · filed 2015-08-06 | $93.58K derived: sum of 4 quarters · filed 2015-08-06 | |||||||||||||
| 2014-03-31 | $25.70K 10-Q · filed 2015-05-07 | $40.75K derived: sum of 2 quarters · filed 2015-05-07 | $49.22K derived: sum of 3 quarters · filed 2015-05-07 | $41.18K derived: sum of 4 quarters · filed 2015-05-07 | $49.51K 10-Q · filed 2014-05-09 | ||||||||||||
| 2013-12-31 | $15.05K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $23.52K derived: sum of 2 quarters · filed 2015-03-11 | $15.47K derived: sum of 3 quarters · filed 2015-03-11 | $23.21K 10-K · filed 2015-03-11 | $23.81K 10-K · filed 2014-03-19 | ||||||||||||
| 2013-09-30 | $8.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $425.00 derived: sum of 2 quarters · filed 2014-11-12 | $8.17K 10-Q · filed 2014-11-12 | $7.17K derived: sum of 4 quarters · filed 2014-11-12 | $8.76K 10-Q · filed 2013-11-04 | ||||||||||||
| 2013-06-30 | -$8.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$302.00 10-Q · filed 2014-08-12 | -$1.30K derived: sum of 3 quarters · filed 2014-08-12 | -$16.21K derived: sum of 4 quarters · filed 2014-08-12 | $293.00 10-Q · filed 2013-08-06 | ||||||||||||
| 2013-03-31 | $7.74K 10-Q · filed 2014-05-09 | $6.75K derived: sum of 2 quarters · filed 2014-05-09 | -$8.16K derived: sum of 3 quarters · filed 2014-05-09 | $336.00 derived: sum of 4 quarters · filed 2014-05-09 | $8.34K 10-Q · filed 2013-05-09 | ||||||||||||
| 2012-12-31 | -$995.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | -$15.91K derived: sum of 2 quarters · filed 2014-03-19 | -$7.41K derived: sum of 3 quarters · filed 2014-03-19 | -$2.84K 10-K · filed 2014-03-19 | $595.00 10-K · filed 2013-03-15 | ||||||||||||
| 2012-09-30 | -$14.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$6.41K derived: sum of 2 quarters · filed 2013-11-04 | -$1.84K 10-Q · filed 2013-11-04 | -$2.95K derived: sum of 4 quarters · filed 2013-11-04 | $1.59K 10-Q · filed 2012-11-08 | ||||||||||||
| 2012-06-30 | $8.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $13.07K 10-Q · filed 2013-08-06 | $11.96K derived: sum of 3 quarters · filed 2013-08-06 | $16.50K derived: sum of 4 quarters · filed 2013-08-06 | $16.50K 10-Q · filed 2012-08-08 | ||||||||||||
| 2012-03-31 | $4.57K 10-Q · filed 2013-05-09 | $3.46K derived: sum of 2 quarters · filed 2013-05-09 | $8.00K derived: sum of 3 quarters · filed 2013-05-09 | -$3.40K derived: sum of 4 quarters · filed 2013-05-09 | $8.00K 10-Q · filed 2012-05-08 | ||||||||||||
| 2011-12-31 | -$1.11K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $3.43K derived: sum of 2 quarters · filed 2013-03-15 | -$7.97K derived: sum of 3 quarters · filed 2013-03-15 | -$7.97K 10-K · filed 2013-03-15 | $3.43K 10-K · filed 2012-03-19 | ||||||||||||
| 2011-09-30 | $4.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$6.86K derived: sum of 2 quarters · filed 2012-11-08 | -$6.86K 10-Q · filed 2012-11-08 | -$20.84K derived: sum of 4 quarters · filed 2012-11-08 | $4.54K 10-Q · filed 2011-11-08 | ||||||||||||
| 2011-06-30 | -$11.40K 10-Q · filed 2011-08-09 | -$11.40K 10-Q · filed 2012-08-08 | -$25.39K derived: sum of 3 quarters · filed 2012-05-08 | $0.00 10-Q · filed 2011-08-09 | |||||||||||||
| 2011-03-31 | -$11.07K 10-Q · filed 2012-05-08 | -$13.98K derived: sum of 2 quarters · filed 2012-05-08 | $330.00 10-Q · filed 2011-05-12 | ||||||||||||||
| 2010-12-31 | -$2.91K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-19 | -$2.91K 10-K · filed 2012-03-19 | |||||||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-08 | ||||||||||||||||
| 2010-06-30 | $2.38K 10-Q · filed 2011-08-09 | $4.06K derived: sum of 2 quarters · filed 2011-08-09 | |||||||||||||||
| 2010-03-31 | $1.67K 10-Q · filed 2011-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |